Efficacy and safety of DPP-4 inhibitors in elderly patients with type 2 diabetes / 中国糖尿病杂志

ABSTRACT

DPP-4 inhibitors are a new type of oral glucose lowering drugs based on pancreatic glucagon. There are 5 kinds of DPP-4 inhibitors that are approved in our country. Currently, DPP-4 inhibitors have been widely recommended by domestic and international diabetes treatment guidelines. The safety of DPP-4 inhibitors is particularly important in elderly patients because this is the main population in type 2 diabetes. Here, we reviewed the literatures, explore the effectiveness and safety of DPP-4 inhibitors in elderly population, and provide evidence for clinical practice.